Article

Pink ophthalmic lens sales support breast cancer research

Volk Optical and Pioneer International have donated $30,000 to the American Cancer Society after selling 1,000 limited-edition diagnostic and treatment lenses.

Mentor, OH-Ophthalmic lens designer and manufacturer Volk Optical and the distributor of its products, Pioneer International, have donated $30,000 to the American Cancer Society after selling 1,000 of the limited-edition diagnostic and treatment lenses Volk developed in 2009 to support Pioneer’s philanthropic efforts.

The lenses, available in 20-, 78-, and 90-D versions as well as in a digital wide-field model, are ringed in the signature pink of breast cancer awareness and are engraved with the awareness ribbon. They are available exclusively from Pioneer.

The sale of each lens in the line results in $30-$10 of the purchase price and matching funds of $10 each from Volk and Pioneer-being donated to breast cancer research. The campaign originated in observance of Pioneer’s 10th anniversary.

“Statistically, one in eight U.S. women will develop invasive breast cancer over the course of her lifetime,” said Valerie Nicola, founder and chief executive officer of Pioneer. “With this disease [affecting] not only women but the lives of their loved ones, we felt it important to unite with Volk in an effort to support new discoveries and a better understanding of cancer and its treatment.”

To order the lenses, contact Pioneer at 888/206-5380 or visit www.pioneerdoctor.com.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.